Thiem D Phan
Examiner (ID: 7633)
Most Active Art Unit | 3729 |
Art Unit(s) | 3729 |
Total Applications | 2341 |
Issued Applications | 1787 |
Pending Applications | 105 |
Abandoned Applications | 401 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5096248
[patent_doc_number] => 20070117857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-24
[patent_title] => 'Substituted 3-amido-tetrahydro-indazolyl cannabinoid modulators'
[patent_app_type] => utility
[patent_app_number] => 11/522756
[patent_app_country] => US
[patent_app_date] => 2006-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18382
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20070117857.pdf
[firstpage_image] =>[orig_patent_app_number] => 11522756
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/522756 | Substituted 3-amido-tetrahydro-indazolyl cannabinoid modulators | Sep 17, 2006 | Abandoned |
Array
(
[id] => 5194425
[patent_doc_number] => 20070082909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-12
[patent_title] => 'Acyclic Ikur inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/518483
[patent_app_country] => US
[patent_app_date] => 2006-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32656
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20070082909.pdf
[firstpage_image] =>[orig_patent_app_number] => 11518483
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/518483 | Acyclic IKur inhibitors | Sep 7, 2006 | Issued |
Array
(
[id] => 243467
[patent_doc_number] => 07589202
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-15
[patent_title] => 'Substituted pyrazoles'
[patent_app_type] => utility
[patent_app_number] => 11/517062
[patent_app_country] => US
[patent_app_date] => 2006-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38805
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/589/07589202.pdf
[firstpage_image] =>[orig_patent_app_number] => 11517062
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/517062 | Substituted pyrazoles | Sep 6, 2006 | Issued |
Array
(
[id] => 8165170
[patent_doc_number] => 08173819
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-08
[patent_title] => 'Nicotinic and picolinic acid derived near-infrared fluorophores'
[patent_app_type] => utility
[patent_app_number] => 12/065391
[patent_app_country] => US
[patent_app_date] => 2006-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15118
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/173/08173819.pdf
[firstpage_image] =>[orig_patent_app_number] => 12065391
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/065391 | Nicotinic and picolinic acid derived near-infrared fluorophores | Aug 31, 2006 | Issued |
Array
(
[id] => 5149513
[patent_doc_number] => 20070049573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'Pyrrole-Derivatives as Factor Xa Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/467277
[patent_app_country] => US
[patent_app_date] => 2006-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34058
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20070049573.pdf
[firstpage_image] =>[orig_patent_app_number] => 11467277
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/467277 | Pyrrole-derivatives as factor Xa inhibitors | Aug 24, 2006 | Issued |
Array
(
[id] => 260193
[patent_doc_number] => 07572920
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-11
[patent_title] => 'Benzimidazole derivative and use as a II receptor antagonist'
[patent_app_type] => utility
[patent_app_number] => 11/466633
[patent_app_country] => US
[patent_app_date] => 2006-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12612
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/572/07572920.pdf
[firstpage_image] =>[orig_patent_app_number] => 11466633
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/466633 | Benzimidazole derivative and use as a II receptor antagonist | Aug 22, 2006 | Issued |
Array
(
[id] => 5023533
[patent_doc_number] => 20070149499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-28
[patent_title] => 'Process for preparing beta-lactamase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/508037
[patent_app_country] => US
[patent_app_date] => 2006-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15069
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20070149499.pdf
[firstpage_image] =>[orig_patent_app_number] => 11508037
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/508037 | Process for preparing beta-lactamase inhibitors | Aug 21, 2006 | Abandoned |
Array
(
[id] => 7724463
[patent_doc_number] => 08097734
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-17
[patent_title] => 'Crystalline sodium atorvastatin'
[patent_app_type] => utility
[patent_app_number] => 11/504104
[patent_app_country] => US
[patent_app_date] => 2006-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3862
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 205
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/097/08097734.pdf
[firstpage_image] =>[orig_patent_app_number] => 11504104
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/504104 | Crystalline sodium atorvastatin | Aug 14, 2006 | Issued |
Array
(
[id] => 4461595
[patent_doc_number] => 07879997
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-01
[patent_title] => 'Compounds for the treatment of inflammatory disorders'
[patent_app_type] => utility
[patent_app_number] => 11/502116
[patent_app_country] => US
[patent_app_date] => 2006-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18983
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/879/07879997.pdf
[firstpage_image] =>[orig_patent_app_number] => 11502116
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/502116 | Compounds for the treatment of inflammatory disorders | Aug 9, 2006 | Issued |
Array
(
[id] => 5057651
[patent_doc_number] => 20070060573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Acyltryptophanols'
[patent_app_type] => utility
[patent_app_number] => 11/501228
[patent_app_country] => US
[patent_app_date] => 2006-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 104270
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20070060573.pdf
[firstpage_image] =>[orig_patent_app_number] => 11501228
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/501228 | Acyltryptophanols | Aug 8, 2006 | Abandoned |
Array
(
[id] => 7703173
[patent_doc_number] => 08088928
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-03
[patent_title] => 'Sirtuin modulating compounds'
[patent_app_type] => utility
[patent_app_number] => 11/499901
[patent_app_country] => US
[patent_app_date] => 2006-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 126807
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/088/08088928.pdf
[firstpage_image] =>[orig_patent_app_number] => 11499901
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/499901 | Sirtuin modulating compounds | Aug 3, 2006 | Issued |
Array
(
[id] => 5154982
[patent_doc_number] => 20070037865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-15
[patent_title] => 'Sirtuin modulating compounds'
[patent_app_type] => utility
[patent_app_number] => 11/499920
[patent_app_country] => US
[patent_app_date] => 2006-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 126783
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 65
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20070037865.pdf
[firstpage_image] =>[orig_patent_app_number] => 11499920
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/499920 | Sirtuin modulating compounds | Aug 3, 2006 | Abandoned |
Array
(
[id] => 892605
[patent_doc_number] => 07345178
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-03-18
[patent_title] => 'Sirtuin modulating compounds'
[patent_app_type] => utility
[patent_app_number] => 11/499919
[patent_app_country] => US
[patent_app_date] => 2006-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 126761
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/345/07345178.pdf
[firstpage_image] =>[orig_patent_app_number] => 11499919
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/499919 | Sirtuin modulating compounds | Aug 3, 2006 | Issued |
Array
(
[id] => 4576005
[patent_doc_number] => 07855289
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-21
[patent_title] => 'Sirtuin modulating compounds'
[patent_app_type] => utility
[patent_app_number] => 11/499876
[patent_app_country] => US
[patent_app_date] => 2006-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 126799
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/855/07855289.pdf
[firstpage_image] =>[orig_patent_app_number] => 11499876
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/499876 | Sirtuin modulating compounds | Aug 3, 2006 | Issued |
Array
(
[id] => 5154944
[patent_doc_number] => 20070037827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-15
[patent_title] => 'Sirtuin modulating compounds'
[patent_app_type] => utility
[patent_app_number] => 11/499239
[patent_app_country] => US
[patent_app_date] => 2006-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 126771
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 44
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20070037827.pdf
[firstpage_image] =>[orig_patent_app_number] => 11499239
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/499239 | Sirtuin modulating compounds | Aug 3, 2006 | Issued |
Array
(
[id] => 5107768
[patent_doc_number] => 20070066646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-22
[patent_title] => 'Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/461782
[patent_app_country] => US
[patent_app_date] => 2006-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23415
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0066/20070066646.pdf
[firstpage_image] =>[orig_patent_app_number] => 11461782
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/461782 | Compounds for Inhibiting Copper-Containing Amine Oxidases and Uses Thereof | Aug 1, 2006 | Abandoned |
Array
(
[id] => 5564970
[patent_doc_number] => 20090137823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => '(E)-N-Monoalkyl-3-Oxo-3-(2-Thienyl) Propenamine and Process for Producing the Same and Process for Producing (E,Z)-N-Monoalkyl-3-Oxo-3-(2-Thienyl) Propenamine'
[patent_app_type] => utility
[patent_app_number] => 11/989100
[patent_app_country] => US
[patent_app_date] => 2006-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4043
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20090137823.pdf
[firstpage_image] =>[orig_patent_app_number] => 11989100
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/989100 | (E)-N-monoalkyl-3-oxo-3-(2-thienyl) propenamine and process for producing the same and process for producing (E,Z)-N-monoalkyl-3-oxo-3-(2-thienyl) propenamine | Jul 31, 2006 | Issued |
Array
(
[id] => 8152516
[patent_doc_number] => 08168793
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-01
[patent_title] => 'Nitrocatechol derivatives as COMT inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/989447
[patent_app_country] => US
[patent_app_date] => 2006-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26420
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/168/08168793.pdf
[firstpage_image] =>[orig_patent_app_number] => 11989447
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/989447 | Nitrocatechol derivatives as COMT inhibitors | Jul 25, 2006 | Issued |
Array
(
[id] => 5733508
[patent_doc_number] => 20060258625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Process for the preparation of biphosphonic derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/491696
[patent_app_country] => US
[patent_app_date] => 2006-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1982
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20060258625.pdf
[firstpage_image] =>[orig_patent_app_number] => 11491696
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/491696 | Process for the preparation of biphosphonic derivatives | Jul 23, 2006 | Issued |
Array
(
[id] => 5733510
[patent_doc_number] => 20060258627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Resistance-repellent retroviral protease inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/490261
[patent_app_country] => US
[patent_app_date] => 2006-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 28772
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20060258627.pdf
[firstpage_image] =>[orig_patent_app_number] => 11490261
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/490261 | Resistance-repellent retroviral protease inhibitors | Jul 20, 2006 | Issued |